Comparisons between the two age groups within the COVID-19 (+) patients (Table 2) indicates that patients ≥65 years of age have a reduced plasma ADAMTS13 activity (remaining in the reference range), as well as increased VWF:AG, VWF:CBA, and VWF/ADAMTS13 activity ratio. Here, ADAMTS13 is linked to COVID-19.